Gideon M. Hirschfield

Overview

Best Publications

• C-reactive protein: a critical update

  Mark B. Pepys;Gideon M. Hirschfield

  5459
  Citations

• C-Reactive Protein and Other Circulating Markers of Inflammation in the Prediction of Coronary Heart Disease

  John Danesh;Jeremy G Wheeler;Gideon M Hirschfield;Shinichi Eda

  4149
  Citations

• The gut microbiota and host health: a new clinical frontier

  Julian Roberto Marchesi;David H. Adams;Francesca Fava;Gerben D. A. Hermes

  2479
  Citations

• EASL Clinical Practice Guidelines: The diagnosis and management of patients with primary biliary cholangitis

  Gideon M. Hirschfield;Ulrich Beuers;Christophe Corpechot;Pietro Invernizzi

  1221
  Citations

• A Placebo-Controlled Trial of Obeticholic Acid in Primary Biliary Cholangitis

  F. Nevens;P. Andreone;G. Mazzella;S. I. Strasser

  1048
  Citations

• Targeting C-reactive protein for the treatment of cardiovascular disease

  Mark B Pepys;Gideon M Hirschfield;Glenys A Tennent;J Ruth Gallimore

  908
  Citations

• Primary biliary cirrhosis associated with HLA, IL12A, and IL12RB2 variants.

  Gideon M. Hirschfield;Xiangdong Liu;Chun Xu;Yue Lu

  693
  Citations

• Efficacy of obeticholic acid in patients with primary biliary cirrhosis and inadequate response to ursodeoxycholic acid

  Gideon M. Hirschfield;Andrew Mason;Velimir Luketic;Velimir Luketic;Keith Lindor;Keith Lindor

  650
  Citations

• Primary sclerosing cholangitis

  Gideon M Hirschfield;Tom H Karlsen;Tom H Karlsen;Keith D Lindor;David H Adams

  610
  Citations

• Overlap syndromes: The International Autoimmune Hepatitis Group (IAIHG) position statement on a controversial issue

  Kirsten Muri Boberg;Roger W Chapman;Gideon M Hirschfield;Ansgar W Lohse

  590
  Citations

• Levels of alkaline phosphatase and bilirubin are surrogate end points of outcomes of patients with primary biliary cirrhosis: An international follow-up study

  Willem J. Lammers;Henk R. van Buuren;Gideon M. Hirschfield;Harry L.A. Janssen

  554
  Citations

• Genome-wide meta-analyses identify three loci associated with primary biliary cirrhosis

  Xiangdong Liu;Pietro Invernizzi;Yue Lu;Roman Kosoy

  470
  Citations

• Patient Age, Sex, and Inflammatory Bowel Disease Phenotype Associate With Course of Primary Sclerosing Cholangitis

  Tobias J. Weismüller;Tobias J. Weismüller;Palak J. Trivedi;Annika Bergquist;Mohamad Imam;Mohamad Imam

  452
  Citations

• Development and Validation of a Scoring System to Predict Outcomes of Patients With Primary Biliary Cirrhosis Receiving Ursodeoxycholic Acid Therapy

  Willem J. Lammers;Gideon M. Hirschfield;Christophe Corpechot;Frederik Nevens

  443
  Citations

• C-reactive protein and cardiovascular disease: new insights from an old molecule.

  G.M. Hirschfield;M.B. Pepys

  420
  Citations

• Dense genotyping of immune-related disease regions identifies nine new risk loci for primary sclerosing cholangitis

  Jimmy Z Liu;Johannes Roksund Hov;Trine Folseraas;Trine Folseraas;Eva Ellinghaus

  418
  Citations

• Primary Biliary Cirrhosis

  Gideon M Hirschfield;E Jenny Heathcote

  398
  Citations

• Baseline Ductopenia and Treatment Response Predict Long-Term Histological Progression in Primary Biliary Cirrhosis

  Teru Kumagi;Maha Guindi;Sandra E Fischer;Tamara Arenovich

  397
  Citations

• The Immunobiology and Pathophysiology of Primary Biliary Cirrhosis

  Hirschfield Gm;Gershwin Me

  385
  Citations

• The UK-PBC risk scores: Derivation and validation of a scoring system for long-term prediction of end-stage liver disease in primary biliary cholangitis

  Marco Carbone;Stephen J. Sharp;Steve Flack;Dimitrios Paximadas

  362
  Citations